Skip to player
Skip to main content
Skip to footer
Search
Connect
Watch fullscreen
Like
Comments
Bookmark
Share
Add to Playlist
Report
Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
Benzinga
Follow
10/2/2024
Eli Lilly's valuation stands at $842 billion, 54x projected earnings. Orforglipron could be the first small-molecule weight-loss pill when it launches in 2026, giving Eli Lilly two-year lead before rivals catch
Category
🗞
News
Recommended
1:04
|
Up next
Jim Cramer Sees Eli Lilly As More Than A 'One-Trick Pony' After FDA Advisors Back Its Alzheimer's Drug: 'It's Ultimately Headed To A Trillion Dollar Valuation'
Benzinga
6/12/2024
1:00
Snowflake Jumps 8% Pre-Market After Piper Sander Hikes Price Target To $215, Calls It 'High-Conviction Growth Play'
Benzinga
5/22/2025
4:16
Piper's Sandler's Craig Johnson Puts $6,600 Target On $SPX For 2025
Benzinga
10/24/2024
1:00
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
Benzinga
5/2/2024
0:58
Charlie Munger Revealed What Was Left On His Bucket List Before He Died
Benzinga
11/30/2023
6:39
What turns around the value stocks?
Benzinga
10/18/2023
4:15
Something Is Happening In The Utilities Sector That Investors Should Watch Out For | $XLU
Benzinga
9/27/2024
0:37
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
Benzinga
7/9/2024
4:17
Apple Stock Dips After KeyBanc Cuts Rating On iPhone Sale Concerns: What Investors Need To Know
Benzinga
10/25/2024
1:12
Warren Buffett's Berkshire Hathaway, Elon Musk's Tesla And Eli Lilly Could Be Next Trillion-Dollar Companies After Nvidia's Rapid Ascension: Jim Cramer
Benzinga
2/27/2024
1:04
Advanced Micro Devices Stock Pops On $6 Billion Buyback Plan, US Tariff Ease
Benzinga
5/14/2025
1:00
Billionaire Bill Ackman's Hedge Fund Pershing Square To Go Public At $50 Per Share
Benzinga
6/28/2024
2:45
Can The S&P 500 Reach $6000 Before Year End? | Jay Woods, CMT, Chief Global Strategist, Freedom Markets
Benzinga
9/27/2024
0:39
Apple Stock Drops 14% in 2025 As Growth, AI, And China Risks Weigh On Tech Giant
Benzinga
3/15/2025
13:34
"The Second Half Of September Is When The Trouble Tends To Come" - Ryan Detrick, CMT, Carson Group
Benzinga
9/5/2024
1:40
Is Managing Volatility Really An Asset Class?
Benzinga
11/2/2023
4:07
Nike Q1 Earnings Highlights: EPS Beats As North American Sales Slide, Shares Move Higher
Benzinga
9/29/2023
1:11
Microsoft Races To The Top, Hits $3-Trillion Valuation, Challenges Apple's Throne
Benzinga
1/24/2024
3:04
How End Of Month Buy And Sell Imbalances Effected Stock Movements
Benzinga
6/1/2023
1:27
Jim Cramer Says Investors Should Check Share Count Before Buying A Stock: 'You Want A Management That Agrees With You'
Benzinga
4/1/2024
17:00
Volatility And Momentum In The Market - Cameron Dawson, CIO NewEdge Wealth
Benzinga
7/24/2024
4:01
Is Japan The Right Country To Invest In Right Now? - Jeremy Schwartz, Global Chief Investment Officer @WisdomTreeFunds
Benzinga
4/28/2023
7:13
From Meme to Market: Apu Apustaja's Journey to a $380M Market Cap
Benzinga
7/22/2024
0:52
Lululemon Q3 Earnings: Revenue Beat, EPS Beat, $1B Buyback Increase, 'Continued Momentum' Across International Markets
Benzinga
12/6/2024
0:40
Tech Stocks Lose Over $2 Trillion Combined As Goldman Sachs Rebrands The Group The 'Maleficent 7'
Benzinga
3/15/2025